✦ LIBER ✦

Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities

✍ Scribed by W Hiddemann; G Jahns-Streubel; W Verbeek; B Wörmann; D Haase; C Schoch

Book ID: 114119448
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 52 KB
Volume: 22
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(98)00037-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Clinical and Biologic Significance o

The Clinical and Biologic Significance of Abnormal Lipid Profiles in Patients with Myelodysplastic Syndromes

✍ Allampallam, K.; Dutt, D.; Nair, C.; Shetty, V.; Mundle, S.; Lisak, L.; Andrews, 📂 Article 📅 2000 🏛 Mary Ann Liebert 🌐 English ⚖ 204 KB

The challenge of individualised risk ass

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients

✍ Reinhard Stauder 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 398 KB

The prognostic significance of cytokine

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes

✍ Apostolia Maria Tsimberidou; Elihu Estey; Sijin Wen; Sherry Pierce; Hagop Kantar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Fludarabine, cytarabine, and granulocyte

Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes

✍ Felicetto Ferrara; Franco Leoni; Antonio Pinto; Salvatore Mirto; Enrica Morra; V 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The prognosis of patients with high risk myelodysplastic syndromes (MDS) (i.e., refractory anemia with excess of blasts [RAEB] and refractory anemia with excess of blasts in transformation [RAEB-t]) usually is poor. The combination of fludarabine, cytarabine, and granulocyte-colony

49 The influence of cytogenetic abnormal

49 The influence of cytogenetic abnormalities on treatment outcome after intensive antileukemic therapy for patients with high risk MDS

✍ T. De Witte; S. Suciu; M. Boogaerts; B. Labar; E. Archimbaud; C. Aul; D. Sellesl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Incidence and significance of primary ab

Incidence and significance of primary abnormalities of cardiac rhythm in infants at high risk for sudden infant death syndrome

✍ Steven D. Colan; Richard R. Liberthson; Lucienne Cahen; Daniel C. Shannon; Dorot 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 455 KB